The Hospital Market in China is growing steadily and has huge potential to grow in the near future. It is primarily driven by government policies and reforms. A strong need to meet the ever increasing healthcare demand drives the market. The huge scope for services in China has made it lucrative for players to venture into this sector. High economic growth and increasing healthcare spending also provides a boost to the market.

The report begins with a market overview section which gives an insight into the overall healthcare scenario in China along with the growth of hospitals and share of hospital ownership. It further delves into the present status of hospital infrastructure in China, growth of hospital beds, hospital bed occupancy rate and the growth of patient visits. This is followed by information regarding the various segments in hospitals, patient referral system and general hospital tendering process.

An analysis of drivers and challenges explains the factors leading to the growth of the market and include growth in GDP and healthcare spending, increasing penetration of medical insurance, rising middle class and increasing ability to pay, aging population, evolution of medical tourism and changes in lifestyle leading to new health problems. The key challenges identified are huge population, unbalanced medical resource allocation and hurdles for the private sector.

The healthcare reform policy adopted by the Chinese Government has been highlighted and includes healthcare reform policy development, health insurance reforms, primary care reforms, private hospitals reforms and government support policies.

Key trends in the market have also been analyzed which includes large hospitals to provide premium services, primary and secondary care providers invest more in facilities, private hospitals to cater to affluent demographics and hospitals receiving strong foreign direct investments.

The competition section provides an overview of the competitive landscape in this industry and includes a brief profile of the major domestic and foreign players in the market.

Page 1: Executive Summary
Market Overview
Page 2: Hospital Market - Overview, Growth of Hospitals (2004-2009), Share of Hospital Ownership (2010)
Page 3: Hospital Infrastructure, Growth in Hospital Beds (2006-2009), Hospital Bed Occupancy Rate (2006-2009), Patients Visiting Hospitals (2009-2009)
Page 4: Hospital Segmentation in China
Page 5: Patient Referral System
Page 6: General Hospital Tendering Process
Drivers & Challenges
Page 7: Summary
Page 8-13: Drivers
Page 14-16: Challenges
Healthcare Reform Policy
Page 17: Summary
Page 18-19: Healthcare Reform Policy Development
Page 20: Health Insurance Reforms
Page 21: Primary Care Reforms
Page 22: Private Hospitals Reforms
Page 23: Government Support Policies
Trends
Page 24: Summary
Page 25-26: Key Trends
Competition
Page 27-32: Snapshots of domestic players
Page 33-36: Snapshot of foreign players

Hospital Supplies and Consumable Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Hospital Supplies and Consumable Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ma...

Hospital Treatment Fee Evaluation Services Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Hospital Treatment Fee Evaluation Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lan...

Modular Hospital Field Solutions Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Modular Hospital Field Solutions Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ma...

Hospital Location Management Software Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Hospital Location Management Software Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscap...

Asia Pacific Idiopathic Pulmonary Fibrosis Market Size, Share, Trends & Analysis by Drug Class (MAPK Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors), by Route of Administration (Oral, Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region, with Forecasts from 2024 to 2034....

Market Overview The Asia Pacific Idiopathic Pulmonary Fibrosis (IPF) Market is expected to witness substantial growth from 2024 to 2034, driven by the rising prevalence of IPF, advancements in drug development, and an increasing focus on early diagnosis and treatment. The market is proj...

Europe Idiopathic Pulmonary Fibrosis Market Size, Share, Trends & Analysis by Drug Class (MAPK Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors), by Route of Administration (Oral, Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region, with Forecasts from 2024 to 2034....

Market Overview The Europe Idiopathic Pulmonary Fibrosis (IPF) Market is expected to witness significant growth between 2024 and 2034, driven by the increasing prevalence of IPF, advancements in drug development, and improved diagnostic methods. The market is projected to reach USD XX.X...

North America Idiopathic Pulmonary Fibrosis Market Size, Share, Trends & Analysis by Drug Class (MAPK Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors), by Route of Administration (Oral, Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region, with Forecasts from 2024 to 2034....

Market Overview The North America Idiopathic Pulmonary Fibrosis (IPF) Market is projected to experience robust growth from 2024 to 2034, driven by advancements in therapeutic options, increasing prevalence of IPF, and a growing emphasis on early diagnosis and treatment. The market size ...

Global Idiopathic Pulmonary Fibrosis Market Size, Share, Trends & Analysis by Drug Class (MAPK Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors), by Route of Administration (Oral, Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region, with Forecasts from 2024 to 2034....

Market Overview The Global Idiopathic Pulmonary Fibrosis (IPF) Market is poised to experience significant growth between 2024 and 2034, driven by advancements in drug development, increasing prevalence of IPF, and heightened awareness about the disease. Valued at USD XX.XX billion in 20...

Asia Pacific Neurofibromatosis Treatment Market Size, Share, Trends & Analysis by Disease Type (Neurofibromatosis 1 (NF1), Neurofibromatosis 2 (NF2), Schwannomatosis), by Treatment (Medications, Surgery, Radiation Therapy, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region, with Forecasts from 2024 to 2034....

Market Overview The Asia Pacific Neurofibromatosis Treatment Market is anticipated to witness substantial growth from 2024 to 2034, driven by increasing awareness and diagnosis of neurofibromatosis (NF), advancements in treatment options, and a growing patient population. The market is ...

Europe Neurofibromatosis Treatment Market Size, Share, Trends & Analysis by Disease Type (Neurofibromatosis 1 (NF1), Neurofibromatosis 2 (NF2), Schwannomatosis), by Treatment (Medications, Surgery, Radiation Therapy, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region, with Forecasts from 2024 to 2034....

Market Overview The Europe Neurofibromatosis Treatment Market is projected to experience substantial growth from 2024 to 2034, driven by advancements in medical treatments, increasing prevalence of neurofibromatosis disorders, and rising awareness about these conditions. The market is e...